Jose Alvarez-Sabín1, Manuel Quintana2, Jaime Masjuan3, Juan Oliva-Moreno4, Javier Mar5, Nuria Gonzalez-Rojas6, Virginia Becerra6, Covadonga Torres7, María Yebenes7. 1. Servei de Neurologia, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain. josalvarez@vhebron.net. 2. Servei de Neurologia, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain. 3. Stroke Unit, Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain. 4. Department of Economic Analysis, Universidad de Castilla La Mancha and REDISSEC, Toledo, Spain. 5. Clinical Management Service, Hospital Alto Deba, Mondragon, Spain. 6. Health Economics and Outcomes Research, Boehringer Ingelheim España, Barcelona, Spain. 7. Pharmacoeconomics and Outcomes Research Iberia, Madrid, Spain.
Abstract
OBJECTIVES: Stroke is a major social and health problem. However, since the recent incorporation of new advances in its management, little is known about the cost of stroke. The aim of this study is to find out the real cost of stroke in Spain. METHODS: This is an epidemiological, observational, prospective, multicenter study of patients diagnosed with stroke and admitted to a stroke unit. Patients were recruited from 16 hospitals throughout Spain and followed up for 1 year. Sociodemographic, clinical, and economic data were collected. Costs (€ 2012) were estimated from the social perspective and were divided into direct healthcare (inpatient, outpatient, and medication), direct non-healthcare (mainly formal and informal care) and labor productivity losses. RESULTS: A total of 321 patients were included. Mean age was 72.1 years and 176 patients (54.8 %) were male. Total average cost per patient/year was €27,711. Direct healthcare costs amounted to €8491 per patient/year (68.8 % due to inpatient costs) and non-healthcare costs to an average of €18,643 per patient/year (89.5 % due to informal care). Productivity loss costs per patient/year were €276. Total costs of hemorrhagic strokes were slightly higher than ischemic (€28,895 vs. €27,569 per patient/year, p = 0.550) without significant differences. The main variables associated with higher costs were the presence of hypertension (€30,332 vs. €23,234 per patient/year, p < 0.05) and the severity of stroke (p < 0.05), both independently associated after a multivariate analysis. CONCLUSIONS: The cost of patients admitted to stroke units in Spain is €27,711 per patient/year. More than two-thirds are social costs, mainly informal care. Stroke remains a major burden on health systems and society, so additional efforts are needed for its prevention.
OBJECTIVES:Stroke is a major social and health problem. However, since the recent incorporation of new advances in its management, little is known about the cost of stroke. The aim of this study is to find out the real cost of stroke in Spain. METHODS: This is an epidemiological, observational, prospective, multicenter study of patients diagnosed with stroke and admitted to a stroke unit. Patients were recruited from 16 hospitals throughout Spain and followed up for 1 year. Sociodemographic, clinical, and economic data were collected. Costs (€ 2012) were estimated from the social perspective and were divided into direct healthcare (inpatient, outpatient, and medication), direct non-healthcare (mainly formal and informal care) and labor productivity losses. RESULTS: A total of 321 patients were included. Mean age was 72.1 years and 176 patients (54.8 %) were male. Total average cost per patient/year was €27,711. Direct healthcare costs amounted to €8491 per patient/year (68.8 % due to inpatient costs) and non-healthcare costs to an average of €18,643 per patient/year (89.5 % due to informal care). Productivity loss costs per patient/year were €276. Total costs of hemorrhagic strokes were slightly higher than ischemic (€28,895 vs. €27,569 per patient/year, p = 0.550) without significant differences. The main variables associated with higher costs were the presence of hypertension (€30,332 vs. €23,234 per patient/year, p < 0.05) and the severity of stroke (p < 0.05), both independently associated after a multivariate analysis. CONCLUSIONS: The cost of patients admitted to stroke units in Spain is €27,711 per patient/year. More than two-thirds are social costs, mainly informal care. Stroke remains a major burden on health systems and society, so additional efforts are needed for its prevention.
Entities:
Keywords:
Cost of illness; Economic impact; Healthcare and non-healthcare costs; Social perspective; Stroke
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2012-12-12 Impact factor: 29.690
Authors: J Masjuan; J Alvarez-Sabín; J Arenillas; S Calleja; J Castillo; A Dávalos; E Díez Tejedor; M Freijo; A Gil-Núñez; J C López Fernández; J F Maestre; E Martínez-Vila; A Morales; F Purroy; J M Ramírez; T Segura; J Serena; J Tejada; C Tejero Journal: Neurologia Date: 2010-11-03 Impact factor: 3.109
Authors: Julio Lopez-Bastida; Juan Oliva Moreno; Melany Worbes Cerezo; Lilisbeth Perestelo Perez; Pedro Serrano-Aguilar; Fernando Montón-Álvarez Journal: BMC Health Serv Res Date: 2012-09-12 Impact factor: 2.655
Authors: Javier Mar; Jaime Masjuan; Juan Oliva-Moreno; Nuria Gonzalez-Rojas; Virginia Becerra; Miguel Ángel Casado; Covadonga Torres; María Yebenes; Manuel Quintana; Jose Alvarez-Sabín Journal: Health Qual Life Outcomes Date: 2015-03-17 Impact factor: 3.186
Authors: Elizabeth Parody-Rua; Alejandro Bustamante; Joan Montaner; Maria Rubio-Valera; David Serrano; Soledad Pérez-Sánchez; Alba Sánchez-Viñas; César Guevara-Cuellar; Antoni Serrano-Blanco Journal: Eur J Health Econ Date: 2022-07-27
Authors: Phuong Bich Tran; Joseph Kazibwe; Georgios F Nikolaidis; Ismo Linnosmaa; Mieke Rijken; Josefien van Olmen Journal: BMC Med Date: 2022-07-19 Impact factor: 11.150
Authors: Fernando de Andrés-Nogales; María Álvarez; María Ángeles de Miquel; Tomás Segura; Alberto Gil; Pere Cardona; Miguel Ángel Casado; Raul G Nogueira; Antoni Dávalos Journal: Eur Stroke J Date: 2017-08-01
Authors: Julio López-Bastida; Luz María Peña-Longobardo; Isaac Aranda-Reneo; Eduardo Tizzano; Mark Sefton; Juan Oliva-Moreno Journal: Orphanet J Rare Dis Date: 2017-08-18 Impact factor: 4.123
Authors: Esteban Jodar; Sara Artola; Xavier Garcia-Moll; Estefany Uría; Noemí López-Martínez; Rosa Palomino; Virginia Martín Journal: BMJ Open Diabetes Res Care Date: 2020-07
Authors: Itziar Oyagüez; Carmen Suárez; José Luis López-Sendón; José Ramón González-Juanatey; Fernando de Andrés-Nogales; Jorge Suárez; Carlos Polanco; Javier Soto Journal: Pharmacoecon Open Date: 2020-09